Indonesia: President Takes Dubious Chinese Coronavirus Vaccine Candidate on Live TV
Indonesian President Joko Widodo received his first dose of CoronaVac, a Chinese-made coronavirus vaccine candidate, on live TV this week.
Indonesian President Joko Widodo received his first dose of CoronaVac, a Chinese-made coronavirus vaccine candidate, on live TV this week.
China’s state-run Global Times on Wednesday put the happiest possible spin on a dismaying Brazilian study that showed China’s Sinovac vaccine candidate for the Chinese coronavirus is only 50 percent effective.
Full data shows China’s Sinovac vaccine candidate, “CoronaVac,” to be 50.38 percent effective against the Chinese coronavirus in late-stage trials, Brazilian state researchers revealed Tuesday, according to the Wall Street Journal.
The world should look to China for its coronavirus vaccines and ignore the alternatives, the Chinese Communist Party (CCP) warned Thursday, adding that to do otherwise is an explicit example of racism.
China’s state-run Global Times newspaper warned Europe that purchasing American-made Chinese coronavirus vaccines was “risky” and that, without significantly transforming “the Western system and lifestyle,” policies to contain the pandemic would fail.
Brazil’s Supreme Federal Tribunal (STF), the highest court in the country, ruled on Thursday that Brazilian authorities could limit the freedoms of individuals who refuse to take a vaccine against the Chinese coronavirus, but could not physically force a person to take it.
Shanghai Fosun Pharmaceutical Group, a Chinese pharmaceutical group, announced Wednesday it had inked a deal with German company BioNTech to purchase 100 million doses of the Chinese coronavirus vaccine it had developed with American company Pfizer — the first vaccine approved for use in the United States.
A Chinese firm conducting trial coronavirus vaccine research is reportedly looking for foreign human guinea pigs to step up and volunteer to test their work.